Immune checkpoint inhibitors have promising clinical activity across multiple gastrointestinal cancers and immune-mediated hepatotoxicity is particularly relevant for this group of patients. In this article we will review the recognition, workup and management of suspected checkpoint inhibitor related immune-hepatitis.
Keywords: Immunotherapy; gastrointestinal cancers; immune checkpoint inhibitors; immune-mediated toxicity.